SLU-PP-332
Pan-ERR agonist
A synthetic pan-estrogen-related-receptor agonist studied in animal models for effects on fatty acid metabolism, sometimes described in press coverage as an exercise mimetic. Preclinical only, with no registered human trials.
Tracking and educational reference only, on values you enter yourself. Not medical advice or a dosing recommendation.
Half-life
Not established in a public source. Half-life is an educational pharmacology figure, drawn from public sources, and is not a schedule or dosing instruction.
Storage & handling
Not approved for human use; no public label defines handling.
References
- PubChem compound record
- J Pharmacol Exp Ther 2024: a synthetic ERR agonist alleviates metabolic syndrome
- Circulation 2024: pan-ERR agonists and cardiac fatty acid metabolism
Read the source
Related in Cognitive / Longevity
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.